Postoperative Survival of Patients with Stage IIIa Non-small Cell Lung Cancer

Postoperative Survival of Patients with Stage IIIa Non-small Cell Lung Cancer

Background and objective At present, surgery is advocated for stage IIIa non-small cell lung cancer (NSCLC), and the survival of them is determined by many factors. The aim of this study is to analyze the influencing factors of prognosis for stage IIIa surgical patients. Methods Between March 2002 a...

Full description

Bibliographic Details
Main Authors:	Huihui LIU, Yan XU, Mengzhao WANG, Ke HU, Manjiao MA, Wei ZHONG, Li ZHANG, Jing ZHAO, Longyun LI, Huazhu WANG
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-11-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplsms Chemotherapy Radiotherapy Influencing factor
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.06

Similar Items

Value of Surgery for Stage IIIa Non-small Cell Lung Cancer
by: Huihui LIU, et al.
Published: (2013-12-01)

Metronomic Chemotherapy - A New Path to Treat Advanced Non-small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2015-04-01)

Clinical Observation of Translating to Small Cell Lung Cancer Following Treatment with EGFR-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma
by: Shuping XUE, et al.
Published: (2015-10-01)

Second-line Chemotherapy and Its Survival Analysis of 181 Patients with Extensive-stage Small Cell Lung Cancer in a Single Institute
by: Manjiao MA, et al.
Published: (2013-11-01)

Multivariate Analysis of Prognostic Factors in the Eldly Patients with Small Cell Lung Cancer: A Study of 160 Patients
by: Xiaoling CHEN, et al.
Published: (2014-01-01)

Advances in Treatment of Brain Metastases  from Primary Non-small Cell Lung Cancer
by: Gen LIN, et al.
Published: (2014-12-01)

Prognostic and Predictive Value of Thyroid Transcription Factor-1, CD56, P40 and Other Clinical Characteristics in Small Cell Lung Cancer Patients
by: Xin WANG, et al.
Published: (2017-08-01)

Efficacy and Safety of Albumin-bound Paclitaxel  in Treating Recurrent Advanced Non-small Cell Lung Cancer
by: Puyuan XING, et al.
Published: (2013-10-01)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
by: Paul E. Van Schil, et al.
Published: (2017-10-01)

Screening of Highly Expressed CPEΔN Lung Cancer H1299 Cells
by: Jing SUN, et al.
Published: (2015-06-01)

Retrospective Study of Efficacy in BIM Gene Polymorphism on First-line EGFR-TKIs Treatment for Advanced Lung Adenocarcinoma
by: Kun QIAN, et al.
Published: (2017-08-01)

First-line Chemotherapy and Its Survival Analysis of 394 Patients with Extensive-stage Small Cell Lung Cancer in a Single Institute
by: Manjiao MA, et al.
Published: (2014-01-01)

Local Treatment Combined with EGFR-TKIs for Advanced Non-small Cell Lung Cancer with Solitary Progression during EGFR-TKI Treatment
by: Xin ZHANG, et al.
Published: (2013-10-01)

Review on Treatment Modalities for Resectable IIIa/N2 Non-small Cell Lung Cancer
by: Ziyi XU, et al.
Published: (2019-02-01)

State of cellular and humoral immune system in women of reproductive age with tumor-like ovary formations
by: O. S. Shapoval, et al.
Published: (2014-12-01)

Advanced Research of Fibroblast Growth Factor Receptor  in Non-small Cell Lung Cancer
by: Dan PU, et al.
Published: (2013-11-01)

Influence of lifestyle, depression, and marital intimacy on quality of life in breast cancer survivors
by: Su-Jin Seo, et al.
Published: (2020-03-01)

Research Progress of the Resistance Mechanism of Non-small Cell Lung Cancer  to EGFR-TKIs
by: Huihui LIU, et al.
Published: (2013-10-01)

Concurrent chemoradiotherapy with low-dose weekly docetaxel followed by consolidation chemotherapy with docetaxel and cisplatin in the treatment of stage III non-small cell lung cancer
by: Tianlin XIAO, et al.
Published: (2008-02-01)

Risk factors for brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, radiotherapy and chemotherapy
by: Petrović Marina, et al.
Published: (2011-01-01)

Diagnosis and Treatment of Leptomeningeal Metastasis in Non-small Cell Lung Cancer
by: Yan XU, et al.
Published: (2015-10-01)

Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancer
by: Jing X, et al.
Published: (2016-02-01)

Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number
by: Siwei Wang, et al.
Published: (2017-12-01)

A Retrospective Study of 42 Lung Cancer Patients with Pancreatic Metastases
by: Yu ZHANG, et al.
Published: (2019-04-01)

Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer
by: Shih-Min Lin, et al.
Published: (2021-05-01)

Mechanism of Chlorogenic Acid in Apoptotic Regulation through Notch1  Pathway in Non-small Cell Lung Carcinoma in Animal Level
by: Wei LI, et al.
Published: (2017-08-01)

Impact of thoracic radiation therapy after chemotherapy on survival in extensive‐stage small cell lung cancer: A propensity score‐matched analysis
by: Lei Deng, et al.
Published: (2019-04-01)

Development and external validation of a nomogram for predicting the overall survival of patients with stage II nasopharyngeal carcinoma after curative treatment
by: He SS, et al.
Published: (2019-05-01)

Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma
by: Tian Cuimeng, et al.
Published: (2020-12-01)

Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Tianyu Lei, et al.
Published: (2021-07-01)

A Paired Case Controlled Study Comparing the Short-term Outcomes of Da Vinci RATS and VATS Approach for Non-small Cell Lung Cancer
by: Feng DAI, et al.
Published: (2018-03-01)

External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma
by: Pui-Lam Yip, et al.
Published: (2021-08-01)

Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database
by: Shenhai Wei, et al.
Published: (2017-06-01)

Clinical Application of Adjuvant Treatment after Operation in Patients with Stage IIIa Non-small Cell Lung Cancer
by: Yajie GAO, et al.
Published: (2010-04-01)

Actualización en el tratamiento del cáncer pulmonar de células no pequeñas en etapa IIIA con afectación N2 Update on treatment of stage IIIA non-small cell lung cancer with N2 disease
by: Miguel Emilio García Rodríguez, et al.
Published: (2012-09-01)

Efficacy and Potential Application of Neoadjuvant Chemotherapy in Patients with IIIa Stage Non-small Cell Lung Cancer
by: Cuiping TANG, et al.
Published: (2017-02-01)

Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors
by: Yu H, et al.
Published: (2016-12-01)

Investigation of Prognostic Factors and Survival without Recurrence in Patients with Breast Cancer
by: Ahmad Abdollahi, et al.
Published: (2017-01-01)

A Prospective Randomized Study of Adjuvant Chemotherapy in Resected Stage IIIA-N2 Non-small Cell Lung Cancer
by: Haibo SUN, et al.
Published: (2009-09-01)

Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center
by: Yi-Jou Tai, et al.
Published: (2019-07-01)